Skip to main content
. 2015 Jul 23;9:3877–3884. doi: 10.2147/DDDT.S87609

Table 2.

Efficacy outcome evaluation in Aterofisiol® group versus placebo group

Plaque components Group A (Cardioaspirin® + Aterofisiol®)
N=103
Group B (Cardioaspirin® + placebo)
N=99
P-value
Lipids 0.232±0.018 0.356±0.022 0.032
Cholesterol 0.036±0.006 0.053±0.007 0.041
Collagen 0.198±0.012 0.204±0.010 0.68
Calcium 0.052±0.006 0.047±0.006 0.98

Notes: Unit of measure: mg/mg dry weight. All values are expressed as mean ± standard error medium.